This message was sent to ##Email##
|
|
|
|
|
| ACS CANCER PROGRAMS UPDATES |
| Learn more about CoC 2020 Standards during the November 18 webinar
|
    |
The Commission on Cancer (CoC) will provide an overview of its new accreditation standards in a free webinar at 1:00 pm Central time on November 18, 2019.
In order to accommodate continued high interest in the webinar, a new registration link has been opened; those who signed up before 11:00 am CDT on October 31, 2019, will need to re-register for the webinar.
Optimal Resources for Cancer Care (2020 Standards) is now available for free download from the CoC website. Over the next several months, the CoC is offering additional educational opportunities on the CoC 2020 Standards.
- Three in-person workshops will cover the 2020 standards and the changes to the National Cancer Database (NCDB):
- CoC 2020: A Glimpse into the Future, Rosemont IL, November 21–22, 2019 (sold out)
- CoC 2020: A Glimpse into the Future, Rosemont IL, April 22–23, 2020 (registration opens December 2019)
- CoC 2020: A Glimpse into the Future, Denver, CO, August 28–29, 2020
- Workshop recordings will be available for purchase through the online learning management system (January 2020)
- Overview of the CoC 2020 Standards webinar, November 18, 2019
- A free online series of short webinars will include tips for each standard (early 2020)
- CAnswer Forum Live 2020 will include a series of six webinars addressing the CoC 2020 Standards as well as other program areas (premiering February 2020)
- Monthly highlights will be featured in The Brief
- Presentations are scheduled at meetings and conferences of CoC member organizations (watch for additions to this schedule):
- Association of Cancer Executives (ACE), January 2020
- National Cancer Registrars Association (NCRA), May 2020
To learn more about implementation timelines, education opportunities and other information related to the 2020 standards, please visit the CoC 2020 Standards website.
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
| Submit your questions for December 11 CAnswer Forum Live
|
|
Registration is now open for the next CAnswer Forum Live webinar from 12:00 noon to 1:00 pm CST on December 11. Please submit your questions by 5:00 pm CST on Friday, November 22.
If you missed the September 25 CAnswer Forum Live webinar, the session recording and slides are available on the CAnswer Forum LIVE web page.
| ACS Cancer Programs offer career opportunities for CTRs
|
|
The American College of Surgeons Cancer Programs has two exciting career opportunities for Certified Tumor Registrars (CTR) or CTR-eligible professionals with the National Cancer Database (NCDB) and the American Joint Committee on Cancer (AJCC).
The NCDB, known for collecting data that represent more than 72 percent of newly diagnosed cancer cases nationwide and more than 40 million submitted records, provides tools and resources to help 1,500 CoC-accredited programs improve delivery and quality of care for cancer patients.
The AJCC provides worldwide leadership in the development of evidence-based systems for the classification and management of cancer in collaboration with multidisciplinary organizations dedicated to cancer surveillance and to improving care. This position will join the team working with physician experts around the world in developing the AJCC 9th edition, as well as providing education for, and answering questions from, fellow registrars.
For details, please visit the American College of Surgeons website for careers at ACS.
| |
SERVICE SHOWCASE | Advertisement
|
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more
|
|
| Use of axillary reverse mapping to prevent lymphedema featured in the Bulletin of the American College of Surgeons
|
|
Arguably the most widely published complication of both axillary lymph node dissection (ALND) and sentinel lymph node (SLN) surgery, lymphedema is most likely caused by transection of the major upper extremity lymphatic vessels. Many varied procedures have been developed to try to cure lymphedema without tremendous success. In this month’s issue of the Bulletin, authors from the American College of Surgeons Clinical Research Program (ACS CRP) present a clinical trial studying axillary reverse mapping (ARM) as a tool that may help further refine the technique of axillary staging to prevent the development of lymphedema.
| AJCC seeks volunteers to assist with Cancer Staging System updates
|
|
The American Joint Committee on Cancer (AJCC) is seeking volunteers from across the oncology community to assist with updates to its Cancer Staging System.
The process will include rigorous vetting of the latest information from scientific research and peer-reviewed publications to support changes to the Cancer Staging System and maintain the standard of excellence that the AJCC has established. The AJCC is seeking broad participation from across the disciplines and specialties in oncology to participate in the AJCC’s Expert Panels, the disease-focused groups that collaboratively contribute to authorship of the Cancer Staging System.
Those interested in participating in the update process should complete the online survey by November 18, 2019:
Applications will be reviewed by the AJCC Editorial Committee and Exert Panel Chairs and Leadership.
|
Advertisement
|
|
|
|
|
| The NAPRC surveyor team needs YOU!
|
|
The National Accreditation Program for Rectal Cancer (NAPRC) is seeking physicians to join its accreditation surveyor team. Surveyors conduct on-site visits with rectal cancer programs seeking NAPRC accreditation to assist in verifying a program’s compliance with the NAPRC Standards.
Applicants must be actively practicing physicians specializing in rectal cancer care and working in a program that is NAPRC accredited or is actively working toward NAPRC accreditation. Please visit the NAPRC website for more information on qualifications and to download the application by November 11.
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
The VTI TQI Doppler system, with its disposable probes, provides a reliable solution for transcutaneous and invasive assessment of vasculature during surgery. In reconstructive applications, the TQI system allows for perioperative localization of perforators, assessment of pedicle anastamosis, as well as assessment of flap viability.
|
|
| Webinar reviews best practices in diagnosis and treatment of inflammatory breast cancer
|
|
In a recent webinar on inflammatory breast cancer (IBC) hosted by the National Accreditation Program for Breast Centers (NAPBC) Advocacy and Education Dissemination Committees, Beth Overmoyer, MD, FACP, recommended that physicians move quickly to refer patients presenting with breast inflammation for breast imaging and surgical referral.
“Although uncommon, IBC accounts for a disproportionate percentage of cancer-related deaths,” said Dr. Beth Overmoyer, director of the Inflammatory Breast Cancer Program at Dana Farber Cancer Institute. “There is often a delay in diagnosis arising from health care professionals not including IBC as part of the differential diagnosis of an ‘inflamed’ breast, especially in postmenopausal women.”
In “Best Practices in the Diagnosis and Treatment of Inflammatory Breast Cancer,” Dr. Overmoyer recommended that for postmenopausal women, physicians should refer immediately for breast imaging and evaluation when inflammation is present. For premenopausal women, physicians should prescribe at most one week of antibiotics prior to referral if the symptoms are not completely resolved.
Find registration information and instructions to access the recorded webinar online. This educational activity is approved for 1 AMA PRA Category 1 Credits™ by the American College of Surgeons and for 1 CE Credit by the National Cancer Registrars Association. The provider is approved by the California Board of Registered Nursing, Provider # TBD, for 1 Contact Hours. Access to the webinar is free.
| HEALTH CARE NEWS AND UPDATES |
NPR
The powerful gene-editing technique known as CRISPR has raised a lot of hope in recent years for its potential to offer new ways to treat many diseases, including cancer. But until now, scientists have released very little information about results of tests in patients.
READ MORE
Forbes
Oncologists may soon have another weapon in their arsenal against colorectal cancer. A new injection that causes cancerous tissue to glow in fluorescence has just entered its Phase 3 trial. The injection aims to help surgeons better spot and remove colorectal cancer from the body. French Pharmaceutical company SurgiMab announced that developments on their fluorescent tumor-specific antibody have started their Phase 3 clinical trial and have begun to be tested on colorectal cancer patients in Europe and the U.S.
READ MORE
Scientific American
Azra Raza, an oncologist at Columbia, has watched too many people die from cancer. They include her patients and her husband, also a cancer specialist. She has poured her frustration into a new book, The First Cell: And the Human Costs of Pursuing Cancer to the Last. “No one is winning the war on cancer,” Raza says. Claims of progress are “mostly hype, the same rhetoric from the same self-important voices for the past half century.”
READ MORE
Healthline
There’s a new blood test that aims to detect breast cancer. It’s one of many attempts to create an effective early detection method.
The test could pinpoint breast cancer up to five years before a person shows clinical signs of the disease, according to researchers from the University of Nottingham in the United Kingdom.
READ MORE
Medical Xpress
Patients who have immune systems that are suppressed from diseases or medical therapy are at greatly increased risk for cancers linked to viral infections, particularly squamous cell carcinoma (SCC) of the skin. Although multiple studies have tried to show a link between human papillomavirus (HPV) infections and SCC, none have been able to show that HPVs actually drive the development of these common skin cancers, say Shawn Demehri, investigator in the Center for Cancer Immunology at Massachusetts General Hospital department of Dermatology and the MGH Cancer Center, and colleagues. Instead, working with experimental models and tissue samples from human skin cancer, they found that the presence of "commensal" papillomaviruses — low-risk forms of HPV that dwell on the skin of a large majority of people—appears to have an indirect protective rather than harmful effects against SCC.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the American College of Surgeons Cancer Programs from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The American College of Surgeons and Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
